剂泰科技-P今日盘中股价大跌12.26%，引起了市场的广泛关注。
消息面上，剂泰科技作为全球AI药物递送第一股于近期登陆港交所，该股自上市首日大涨后已连续多个交易日回调。公司尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。随着新股上市初期市场热度加速消退，股价承压回落态势延续。
剂泰科技的IPO发售价为10.50港元，上市后股价经历了显著波动。此次盘中大跌是市场对其估值、基本面以及新股热度退潮后的正常调整反应。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.